Nobel Laureate Foresees HIV Cure

.

Nobel Laureate Foresees HIV Cure

Will there be any cure for HIV ever? Perhaps yes, if the Nobel laureate who played a key role in finding human immunodeficiency virus (HIV), is to be heard. Francoise Barre-Sinoussi is of the view that the way researchers are coming out with some or the other study linked with HIV, it would not be wrong to say that sooner or later, there would be some cure for the disease.

She was awarded with the Nobel Prize in Medicine in 2008. She also shared the case of a patient who managed to get treated from the disease after a bone marrow transplant, thereby proving that there would be some concrete cure of the disease in future. However, she refused to share any fixed date for the same considering the uncertainty which exists till now.

Nonetheless, she is of the view that in case, all the hurdles, including political, economic and social, to drug access are being rooted out, there are fair chances of eliminating the AIDS pandemic by 2050. "At the Washington conference we are expecting greater mobilisation . . . to widen access to current treatments and to continue research into HIV”, she added, who along with some 25,000 people, including celebrities, scientists and HIV patients, would be in the US capital today to voice for taking global action against the scar of AIDS.


Latest News

Teenagers Underestimate Calories in Fast Food
A Smart Phone Application to Detect Toxins, Viruses
Heinrich Rohrer: The Greatest Contributor to Nanotechnology Passes Away
GSK and Health Canada Warns about Unauthorized Product
H7N9 Capable of Combining with Swine Flu to form Novel Virus
Researchers utilize data to Determine Various Kinds of prostate cancers and Trea
Parenting helps Protect Babies from Harmful Genes
Glenn A. Kiser Hospice Ready to Open Doors for Patients
Potatoes Provide Better Nutritional Value for Money
Food supplement CoQ10 may reduce Risk of Heart Failure by 50%
Neurotransmitter Responsible for Itching Found
NHS Culture May Improve by Allowing Hospital Staff Share Challenges they Face